Published in Pediatrics on January 18, 2010
Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis. PLoS Med (2011) 1.83
Noroviruses: The Most Common Pediatric Viral Enteric Pathogen at a Large University Hospital After Introduction of Rotavirus Vaccination. J Pediatric Infect Dis Soc (2012) 1.42
Performance of rotavirus vaccines in developed and developing countries. Hum Vaccin (2010) 1.39
Genetic analyses reveal differences in the VP7 and VP4 antigenic epitopes between human rotaviruses circulating in Belgium and rotaviruses in Rotarix and RotaTeq. J Clin Microbiol (2011) 1.33
Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011. Clin Infect Dis (2013) 1.23
Effectiveness of monovalent and pentavalent rotavirus vaccine. Pediatrics (2013) 1.13
Understanding reduced rotavirus vaccine efficacy in low socio-economic settings. PLoS One (2012) 1.05
Effectiveness of rotavirus vaccine in preventing severe acute gastroenteritis in children. Can Fam Physician (2012) 1.02
Rotavirus vaccines: current status and future considerations. Hum Vaccin Immunother (2014) 1.02
Prevention of rotavirus gastroenteritis in infants and children: rotavirus vaccine safety, efficacy, and potential impact of vaccines. Biologics (2010) 1.00
Effectiveness of rotavirus vaccine in preventing hospitalization due to rotavirus gastroenteritis in young children in Connecticut, USA. Vaccine (2010) 0.98
Effectiveness of monovalent rotavirus vaccine in Bolivia: case-control study. BMJ (2013) 0.97
Vaccination recommendations for Germany. Dtsch Arztebl Int (2011) 0.97
Comparison of 2 assays for diagnosing rotavirus and evaluating vaccine effectiveness in children with gastroenteritis. Emerg Infect Dis (2013) 0.93
Rotavirus vaccines: update on global impact and future priorities. Hum Vaccin (2011) 0.92
Epidemiologic Association Between FUT2 Secretor Status and Severe Rotavirus Gastroenteritis in Children in the United States. JAMA Pediatr (2015) 0.91
Efficacy, immunogenicity, and safety of two doses of a tetravalent rotavirus vaccine RRV-TV in Ghana with the first dose administered during the neonatal period. J Infect Dis (2013) 0.90
Epidemiology and clinical features of gastroenteritis in hospitalised children: prospective survey during a 2-year period in a Parisian hospital, France. Eur J Clin Microbiol Infect Dis (2010) 0.90
The control of rotavirus gastroenteritis in the United States. Trans Am Clin Climatol Assoc (2012) 0.85
Molecular characterization of rotavirus isolates from select Canadian pediatric hospitals. BMC Infect Dis (2012) 0.84
New insights into rotavirus vaccines. Hum Vaccin Immunother (2012) 0.84
Efficacy and safety of pentavalent rotavirus vaccine in Japan: a randomized, double-blind, placebo-controlled, multicenter trial. Hum Vaccin Immunother (2013) 0.81
Potential impact of accelerating the primary dose of rotavirus vaccine in infants. Vaccine (2012) 0.81
Epidemiology and genetic diversity of rotavirus strains in children with acute gastroenteritis in Lahore, Pakistan. PLoS One (2013) 0.81
Pediatric small intestine bacterial overgrowth in low-income countries. Trends Mol Med (2014) 0.80
Determining the effectiveness of the pentavalent rotavirus vaccine against rotavirus hospitalizations and emergency department visits using two study designs. Vaccine (2013) 0.80
Impact of vaccination uptake on hospitalizations due to rotavirus acute gastroenteritis in 2 different socioeconomic areas of Spain. Hum Vaccin Immunother (2016) 0.77
Evaluation of the frequency of immunization information system use for public health research. Hum Vaccin Immunother (2013) 0.76
Effectiveness of rotavirus vaccine in preventing severe gastroenteritis in young children according to socioeconomic status. Hum Vaccin Immunother (2016) 0.75
Bias with respect to socioeconomic status: A closer look at zip code matching in a pneumococcal vaccine effectiveness study. SSM Popul Health (2016) 0.75
Group A rotaviruses in children with gastroenteritis in a Canadian pediatric hospital: The prevaccine era. Can J Infect Dis Med Microbiol (2013) 0.75
Rotavirus Surveillance at a WHO-Coordinated Invasive Bacterial Disease Surveillance Site in Bangladesh: A Feasibility Study to Integrate Two Surveillance Systems. PLoS One (2016) 0.75
A sham case-control study of effectiveness of DTP-Hib-hepatitis B vaccine against rotavirus acute gastroenteritis in Kenya. BMC Infect Dis (2014) 0.75
Laboratory-Confirmed Rotavirus Disease in Utah Children: Clinical and Economic Impact of Rotavirus Vaccination. J Pediatric Infect Dis Soc (2012) 0.75
Cost effectiveness of a pentavalent rotavirus vaccine in Oman. BMC Infect Dis (2014) 0.75
Public Health Impact of Complete and Incomplete Rotavirus Vaccination among Commercially and Medicaid Insured Children in the United States. PLoS One (2016) 0.75
2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis (2011) 7.79
Norovirus gastroenteritis. N Engl J Med (2009) 7.66
Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis (2008) 7.48
Nipah virus encephalitis reemergence, Bangladesh. Emerg Infect Dis (2004) 5.49
Epidemiologic and molecular trends of "Norwalk-like viruses" associated with outbreaks of gastroenteritis in the United States. J Infect Dis (2002) 4.88
Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med (2011) 4.49
Noroviruses: a comprehensive review. J Clin Virol (2008) 4.33
Norovirus and medically attended gastroenteritis in U.S. children. N Engl J Med (2013) 4.09
Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol (2011) 3.87
Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2009) 3.08
Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states. J Infect Dis (2010) 3.02
Rotavirus vaccines: current prospects and future challenges. Lancet (2006) 2.97
Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants. Clin Infect Dis (2012) 2.96
Norovirus disease in the United States. Emerg Infect Dis (2013) 2.92
ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann Emerg Med (2006) 2.86
Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis (2005) 2.82
Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments. Arch Virol (2008) 2.77
Cost-effectiveness and potential impact of rotavirus vaccination in the United States. Pediatrics (2007) 2.75
Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics. Science (2009) 2.67
Group B streptococcal infections in elderly adults. Clin Infect Dis (2005) 2.59
The promise of new rotavirus vaccines. N Engl J Med (2006) 2.58
Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species. Pediatrics (2008) 2.45
The future of rotavirus vaccines: a major setback leads to new opportunities. Lancet (2004) 2.43
Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States. J Infect Dis (2011) 2.43
Rotavirus vaccine and health care utilization for diarrhea in U.S. children. N Engl J Med (2011) 2.41
The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. Clin Infect Dis (2012) 2.34
Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2013) 2.20
Oral rotavirus vaccines: how well will they work where they are needed most? J Infect Dis (2009) 2.12
Final report of the Lyme disease review panel of the Infectious Diseases Society of America. Clin Infect Dis (2010) 2.09
Increasing rates of gastroenteritis hospital discharges in US adults and the contribution of norovirus, 1996-2007. Clin Infect Dis (2011) 1.98
Impact of an emergent norovirus variant in 2009 on norovirus outbreak activity in the United States. Clin Infect Dis (2011) 1.97
Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Clin Infect Dis (2004) 1.96
Trends in pertussis among infants in the United States, 1980-1999. JAMA (2003) 1.94
Incidence of acute gastroenteritis and role of norovirus, Georgia, USA, 2004-2005. Emerg Infect Dis (2011) 1.92
Real-world impact of rotavirus vaccination. Pediatr Infect Dis J (2011) 1.89
Environmental transmission of norovirus gastroenteritis. Curr Opin Virol (2011) 1.87
Severe outcomes are associated with genogroup 2 genotype 4 norovirus outbreaks: a systematic literature review. Clin Infect Dis (2012) 1.86
Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection. Clin Infect Dis (2011) 1.85
Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine. Pediatrics (2009) 1.84
United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction. Pediatr Infect Dis J (2011) 1.83
Projected impact and cost-effectiveness of a rotavirus vaccination program in India, 2008. Clin Infect Dis (2011) 1.79
Multilocus sequence typing of serotype III group B streptococcus and correlation with pathogenic potential. J Infect Dis (2004) 1.73
Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries. J Infect Dis (2009) 1.72
Epidemiology of foodborne norovirus outbreaks, United States, 2001-2008. Emerg Infect Dis (2012) 1.69
Group B Streptococcus colonization in male and nonpregnant female university students: a cross-sectional prevalence study. Clin Infect Dis (2001) 1.66
Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006-2009. Clin Infect Dis (2011) 1.64
Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm. J Infect Dis (2009) 1.64
Diarrhea- and rotavirus-associated hospitalizations among children less than 5 years of age: United States, 1997 and 2000. Pediatrics (2006) 1.64
Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data. Pediatr Infect Dis J (2011) 1.63
Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007. Pediatrics (2008) 1.63
The global burden of diarrhoeal disease in children. Bull World Health Organ (2003) 1.61
First report from the Asian Rotavirus Surveillance Network. Emerg Infect Dis (2004) 1.60
Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States. Pediatrics (2008) 1.58
The role of serum antibodies in the protection against rotavirus disease: an overview. Clin Infect Dis (2002) 1.53
Comparison of DNA dot blot hybridization and lancefield capillary precipitin methods for group B streptococcal capsular typing. J Clin Microbiol (2004) 1.53
Development of candidate rotavirus vaccines derived from neonatal strains in India. J Infect Dis (2005) 1.52
Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil. J Infect Dis (2010) 1.51
Wrestling SARS from uncertainty. Emerg Infect Dis (2004) 1.50
Cluster of SARS among medical students exposed to single patient, Hong Kong. Emerg Infect Dis (2004) 1.49
Multicenter, hospital-based surveillance of rotavirus disease and strains among indian children aged <5 years. J Infect Dis (2009) 1.49
Protective association between rotavirus vaccination and childhood seizures in the year following vaccination in US children. Clin Infect Dis (2013) 1.49
Trends in intussusception hospitalizations among US infants before and after implementation of the rotavirus vaccination program, 2000-2009. J Infect Dis (2012) 1.48
Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum. J Infect Dis (2004) 1.48
Should India launch a national immunisation programme against rotavirus? Yes. BMJ (2012) 1.43
Correlates of antibiotic-resistant group B streptococcus isolated from pregnant women. Obstet Gynecol (2003) 1.42
Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006. Pediatr Infect Dis J (2011) 1.41
Relevance of age at diagnosis to prevention of late-onset group B streptococcal disease by maternal immunization. Pediatr Infect Dis J (2015) 1.39
Performance of rotavirus vaccines in developed and developing countries. Hum Vaccin (2010) 1.39
Secular variation in United States rotavirus disease rates and serotypes: implications for assessing the rotavirus vaccination program. Pediatr Infect Dis J (2009) 1.36
Hospitalizations associated with rotavirus gastroenteritis in the United States, 1993-2002. Pediatr Infect Dis J (2006) 1.35
Rotavirus vaccines: targeting the developing world. J Infect Dis (2005) 1.35
Burden of norovirus gastroenteritis in the ambulatory setting--United States, 2001-2009. J Infect Dis (2013) 1.34
Global impact of rotavirus vaccines. Expert Rev Vaccines (2010) 1.34